Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramucirumab plus chemotherapy in Japanese cancer patients
jRCT2080225150Phase 2Completed
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of ramucirumab. Started Apr 2020; status: completed.
02
Drugs
ramucirumab
Beyond the preview
Go deeper on jRCT2080225150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225150.